Bernadette Connaughton, Director: Halozyme Therapeutics HALO Planned sale · Filed 25/09/02

Trade details

Type: Planned sale notice
Stock: Halozyme Therapeutics HALO
Person: Bernadette ConnaughtonDirector
Planned sale date: 25/09/02
Filed: 25/09/02

$645.8K to be sold

Halozyme Therapeutics trades, last 26 weeks

What else happened in Halozyme Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/03~25/10/02

Bernadette Connaughton's recent trades

Bernadette ConnaughtonDirector
Planned sale10b5-1 planHalozyme Therapeutics
Planned sale10b5-1 plan
Halozyme Therapeutics
HALO
$167.7K
1,626 sh
$167.7K
Filed 08/10
Traded 08/10
Bernadette ConnaughtonDirector
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$107.6K
1,625 sh
$107.6K
Filed 06/02
Traded 06/01
Bernadette ConnaughtonDirector
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$103.2K
1,625 sh
$103.2K
Filed 05/05
Traded 05/01
Bernadette ConnaughtonDirector
Planned sale10b5-1 planHalozyme Therapeutics
Planned sale10b5-1 plan
Halozyme Therapeutics
HALO
$310.3K
4,875 sh
$310.3K
Filed 05/01
Traded 05/01
Bernadette ConnaughtonDirector
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$140.5K
2,000 sh
$140.5K
Filed 01/06
Traded 01/05

Bernadette Connaughton, Director — plans to sell 8,829 sh of Halozyme Therapeutics HALO · $645.8K · around 09/02 · 10b5-1 plan | Whalegun